within Pharmacolibrary.Drugs.ATC.A;

model A12CC08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 0.1,
    adminDuration  = 600,
    adminMass      = 0.37,
    adminCount     = 1,
    Vd             = 0.00025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Magnesium pidolate is a magnesium salt of pidolic acid, used as an oral magnesium supplement. It is indicated in the treatment and prevention of magnesium deficiency, which may manifest as muscle cramps, fatigue, irritability, or cardiac symptoms. It is available over-the-counter in several European countries, but is not widely used or approved in the United States.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies with detailed compartmental parameters found for magnesium pidolate in humans. Estimates below are based on pharmacokinetic literature for oral magnesium salts in adults.</p><h4>References</h4><ol><li>Jeanette A Maier, Gisele Pickering, Elena Giacomoni, Alessandra Cazzaniga, Paolo Pellegrino,Headaches and Magnesium: Mechanisms, Bioavailability, Therapeutic Efficacy and Potential Advantage of Magnesium Pidolate.,Nutrients,2020<a href='https://pubmed.ncbi.nlm.nih.gov/32878232/'>https://pubmed.ncbi.nlm.nih.gov/32878232/</a></li><li>C Coudray, M Rambeau, C Feillet-Coudray, E Gueux, J C Tressol, A Mazur, Y Rayssiguier,Study of magnesium bioavailability from ten organic and inorganic Mg salts in Mg-depleted rats using a stable isotope approach.,Magnesium research,2005<a href='https://pubmed.ncbi.nlm.nih.gov/16548135/'>https://pubmed.ncbi.nlm.nih.gov/16548135/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A12CC08;
